| HGIRX | VFINX | HGIRX / VFINX | |
| Total Expense Ratio | 1.08 | 0.14 | 771% |
| Annual Report Gross Expense Ratio | 1.08 | 0.14 | 771% |
| Fund Existence | 19 years | 49 years | - |
| Gain YTD | 1.091 | 1.131 | 96% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 11.5B | 1.48T | 1% |
| Annual Yield % from dividends | 0.00 | 1.01 | - |
| Returns for 1 year | 1.48 | 15.48 | 10% |
| Returns for 3 years | 34.05 | 67.54 | 50% |
| Returns for 5 years | 30.99 | 78.93 | 39% |
| Returns for 10 years | 158.04 | 268.63 | 59% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SFVLX | 18.79 | 0.30 | +1.62% |
| Seafarer Overseas Value Investor | |||
| FPHAX | 31.97 | N/A | N/A |
| Fidelity Select Pharmaceuticals Port | |||
| DYGAX | 15.46 | N/A | N/A |
| Meeder Dynamic Allocation Adviser | |||
| LAMQX | 25.96 | -0.08 | -0.31% |
| Lord Abbett Dividend Growth R2 | |||
| BALCX | 38.04 | -0.17 | -0.44% |
| American Funds American Balanced C | |||